EP4384278A4 - Antimetastatisches mittel, das auf prostatakrebszellen wirksam ist und zur verwendung bei der behandlung dieser erkrankungen geeignet ist - Google Patents

Antimetastatisches mittel, das auf prostatakrebszellen wirksam ist und zur verwendung bei der behandlung dieser erkrankungen geeignet ist Download PDF

Info

Publication number
EP4384278A4
EP4384278A4 EP22947055.4A EP22947055A EP4384278A4 EP 4384278 A4 EP4384278 A4 EP 4384278A4 EP 22947055 A EP22947055 A EP 22947055A EP 4384278 A4 EP4384278 A4 EP 4384278A4
Authority
EP
European Patent Office
Prior art keywords
diseases
treatment
cancer cells
prostate cancer
agent active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP22947055.4A
Other languages
English (en)
French (fr)
Other versions
EP4384278A1 (de
Inventor
Zeliha GÖKMEN
Engin ULUKAYA
Remzi Okan AKAR
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istinye Ueniversitesi
Istanbul Universitesi Rektorlugu
Original Assignee
Istinye Ueniversitesi
Istanbul Universitesi Rektorlugu
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istinye Ueniversitesi, Istanbul Universitesi Rektorlugu filed Critical Istinye Ueniversitesi
Priority claimed from PCT/TR2022/051215 external-priority patent/WO2024085824A1/en
Publication of EP4384278A1 publication Critical patent/EP4384278A1/de
Publication of EP4384278A4 publication Critical patent/EP4384278A4/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP22947055.4A 2022-10-19 2022-11-01 Antimetastatisches mittel, das auf prostatakrebszellen wirksam ist und zur verwendung bei der behandlung dieser erkrankungen geeignet ist Pending EP4384278A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
TR202215931 2022-10-19
PCT/TR2022/051215 WO2024085824A1 (en) 2022-10-19 2022-11-01 An antimetastatic agent effective on prostate cancer cells and suitable for use in the treatment of these diseases

Publications (2)

Publication Number Publication Date
EP4384278A1 EP4384278A1 (de) 2024-06-19
EP4384278A4 true EP4384278A4 (de) 2024-10-23

Family

ID=91130832

Family Applications (1)

Application Number Title Priority Date Filing Date
EP22947055.4A Pending EP4384278A4 (de) 2022-10-19 2022-11-01 Antimetastatisches mittel, das auf prostatakrebszellen wirksam ist und zur verwendung bei der behandlung dieser erkrankungen geeignet ist

Country Status (1)

Country Link
EP (1) EP4384278A4 (de)

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CHEN D -N ET AL: "Identification of bostrycin derivatives as potential inhibitors of mycobacterium tuberculosis protein tyrosine phosphatase (MptpB)", MEDICINAL CHEMISTRY 20160501 BENTHAM SCIENCE PUBLISHERS B.V. NLD, vol. 12, no. 3, 1 May 2016 (2016-05-01), pages 296 - 302, XP093202088, ISSN: 1573-4064 *
See also references of WO2024085824A1 *
ZELIHA GOKMEN: "Synthesis and investigation of cytotoxicity of new N - and S,S -substituted-1,4-naphthoquinone (1,4-NQ) derivatives on selected cancer lines", SYNTHETIC COMMUNICATIONS, 27 August 2019 (2019-08-27), US, pages 1 - 9, XP093167221, ISSN: 0039-7911, DOI: 10.1080/00397911.2019.1655057 *

Also Published As

Publication number Publication date
EP4384278A1 (de) 2024-06-19

Similar Documents

Publication Publication Date Title
Heinlin et al. Randomized placebo‐controlled human pilot study of cold atmospheric argon plasma on skin graft donor sites
Ghafourian et al. Vitiligo: symptoms, pathogenesis and treatment
DE69534100D1 (de) Diagnose und behandlung von zellproliferativen erkrankungen mit beteiligung von klonalen makrophagen
Khosravi et al. Characteristics and outcomes of nonmelanoma skin cancer (NMSC) in children and young adults
MX2009012197A (es) Metodos para tratamiento de ulceras en la piel.
ATE481978T1 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
NZ597779A (en) Treatment of inflammatory diseases using placental stem cells
UY38766A (es) Derivados de imidazo[1,2-a]piridinilo y su uso en el tratamiento de enfermedades
ATE309802T1 (de) Verwendung von cyclopamine zur behandlung von psoriasis und anderen hauterkrankungen
EP4400105A4 (de) Medikament zur prävention und behandlung von erkrankungen im zusammenhang mit aktivität gegen fettleibigkeit
De Leeuw et al. Treatment of vitiligo with khellin liposomes, ultraviolet light and blister roof transplantation
Li et al. Basic research and clinical exploration of cold atmospheric plasma for skin wounds
UY38765A (es) Derivados de 2h-indazol y su uso en el tratamiento de enfermedades
EP4426322A4 (de) Mesenchymale stammzellen zur prävention und gezielten behandlung von krebs und anderen erkrankungen
Farah et al. Penis tourniquet syndrome and penile amputation
EP4384278A4 (de) Antimetastatisches mittel, das auf prostatakrebszellen wirksam ist und zur verwendung bei der behandlung dieser erkrankungen geeignet ist
JOP20230148A1 (ar) مشتقات إيميدازو بيريدين كمثبطات لـ irak4 واستخدامها في علاج أحد الأمراض
MX2021013351A (es) Terapias de combinacion.
EP4352265A4 (de) Verwendung der krebszellexpression von cadherin 12 und cadherin 18 zur behandlung von blasenkrebs
MX2023013886A (es) Pemafibrato y/o tofogliflozin para uso en el tratamiento de enfermedad del higado.
Plath et al. Tumor control and quality of life in skin cancer patients with extensive multilayered nasal defects
ATE556134T1 (de) Mesenchymstammzellen und verwendungendafür
Ala et al. Effects of silver sulfadiazine and Adibderm® herbal ointments in treatment of patients with second degree burns: a randomized clinical trial
ATE484280T1 (de) Verwendung der kombination aus temozolomid und tnf-alpha zur behandlung von glioblastoma
Malca et al. Our 35 years’ experience on postburn heterotopic ossification: A three-step treatment

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20231227

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: DE

Ref legal event code: R079

Free format text: PREVIOUS MAIN CLASS: A61P0035000000

Ipc: A61K0031122000

A4 Supplementary search report drawn up and despatched

Effective date: 20240919

RIC1 Information provided on ipc code assigned before grant

Ipc: C07C 50/12 20060101ALI20240913BHEP

Ipc: C07C 211/42 20060101ALI20240913BHEP

Ipc: C07C 211/30 20060101ALI20240913BHEP

Ipc: A61P 35/00 20060101ALI20240913BHEP

Ipc: A61K 31/122 20060101AFI20240913BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)